q3 non-gaap earnings per share $1.35.
q1 gaap earnings per share $1.33.
qtrly group revenue $876 million versus refinitiv ibes estimate of $868.7 million.
qtrly covid-19-related revenue was approximately $20 million, a decline of $105 million compared to prior year quarter.
qtrly non-gaap net income of $198 million, an increase of 3%.
qtrly u.s. sales rose 18 percent to $472 million.
compname announces 8% increase in quarterly dividend to $0.42 per share.
qtrly revenue increased 10% in constant currency to $1.2 billion.
qtrly europe, asia, and other markets sales increased 11% to $308 million.
qtrly masks and other sales increased 5 percent to $204 million.
qtrly u.s., canada and latin america device sales increased 30% to $268 million.
compname reports 8% increase in quarterly dividend to $0.20 per share.
compname says believes component supply constraints as they stand will currently limit incremental device revenue attributable to competitor's recall to somewhere between $300 million and $350 million during fiscal 2022.
qtrly europe, asia, and other markets sales rose 36% to $98 million.
qtrly sales under $20 million.
sees fy revenue $300 million to $350 million, up over previously planned revenue growth for fiscal 2022.
